{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:12:21Z","timestamp":1788635541375,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,5]]},"DOI":"10.7759\/cureus.115829","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:56:42Z","timestamp":1788634602000},"source":"Crossref","is-referenced-by-count":0,"title":["Serpin B5 as a Potential Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Maryam","family":"Salik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Arnouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"National Cancer Institute. Cancer Statistics Explorer Network. (2024). Accessed: June 13, 2026: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.02.001","article-title":"Survival outcomes after treatment of cancer of the oral cavity (1985-2015)","volume":"90","author":"Zanoni DK","year":"2019","unstructured":"Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, Patel SG. Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol. 2019, 90:115-21. 10.1016\/j.oraloncology.2019.02.001","journal-title":"Oral Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105451","article-title":"Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics","volume":"121","author":"Chamoli A","year":"2021","unstructured":"Chamoli A, Gosavi AS, Shirwadkar UP, et al.. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021, 121:105451. 10.1016\/j.oraloncology.2021.105451","journal-title":"Oral Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry NL","year":"2012","unstructured":"Henry NL, Hayes DF. Cancer biomarkers. Mol Oncol. 2012, 6:140-6. 10.1016\/j.molonc.2012.01.010","journal-title":"Mol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18132088","article-title":"Current trends in diagnosis and early monitoring of oral cavity cancer: techniques and biomarkers","volume":"18","author":"Marczuk KM","year":"2026","unstructured":"Marczuk KM, Mamala MB, Opalewski A, G\u0142\u00f3wka I, Gerber H, Jaxa-Kwiatkowski A. Current trends in diagnosis and early monitoring of oral cavity cancer: techniques and biomarkers. Cancers (Basel). 2026, 18:2088. 10.3390\/cancers18132088","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3147","article-title":"A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene","volume":"92","author":"Schneider SS","year":"1995","unstructured":"Schneider SS, Schick C, Fish KE, et al.. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A. 1995, 92:3147-51. 10.1073\/pnas.92.8.3147","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/002215549704501213","article-title":"Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface","volume":"45","author":"Pemberton PA","year":"1997","unstructured":"Pemberton PA, Tipton AR, Pavloff N, Smith J, Erickson JR, Mouchabeck ZM, Kiefer MC. Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J Histochem Cytochem. 1997, 45:1697-706. 10.1177\/002215549704501213","journal-title":"J Histochem Cytochem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/72303","article-title":"Maspin is an angiogenesis inhibitor","volume":"6","author":"Zhang M","year":"2000","unstructured":"Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med. 2000, 6:196-9. 10.1038\/72303","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/2001-1326-2-8","article-title":"Role of maspin in cancer","volume":"2","author":"Berardi R","year":"2013","unstructured":"Berardi R, Morgese F, Onofri A, et al.. Role of maspin in cancer. Clin Transl Med. 2013, 2:8. 10.1186\/2001-1326-2-8","journal-title":"Clin Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1017\/S1431927616000520","article-title":"Effects of noninhibitory serpin Maspin on the actin cytoskeleton: a quantitative image modeling approach","volume":"22","author":"Al-Mamun M","year":"2016","unstructured":"Al-Mamun M, Ravenhill L, Srisukkham W, Hossain A, Fall C, Ellis V, Bass R. Effects of noninhibitory serpin Maspin on the actin cytoskeleton: a quantitative image modeling approach. Microsc Microanal. 2016, 22:394-409. 10.1017\/S1431927616000520","journal-title":"Microsc Microanal"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2016.11.019","article-title":"Identification of novel peptide motifs in the serpin maspin that affect vascular smooth muscle cell function","volume":"1864","author":"Jenkinson SE","year":"2017","unstructured":"Jenkinson SE, Brown LJ, Ombor J, et al.. Identification of novel peptide motifs in the serpin maspin that affect vascular smooth muscle cell function. Biochim Biophys Acta Mol Cell Res. 2017, 1864:336-44. 10.1016\/j.bbamcr.2016.11.019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.235788","article-title":"Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion","volume":"286","author":"Endsley MP","year":"2011","unstructured":"Endsley MP, Hu Y, Deng Y, et al.. Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion. J Biol Chem. 2011, 286:24599-607. 10.1074\/jbc.M111.235788","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050497","article-title":"The plasminogen activation system in tumor growth, invasion, and metastasis","volume":"57","author":"Andreasen PA","year":"2000","unstructured":"Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci. 2000, 57:25-40. 10.1007\/s000180050497","journal-title":"Cell Mol Life Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02141.x","article-title":"Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx","volume":"46","author":"Marioni G","year":"2005","unstructured":"Marioni G, Blandamura S, Giacomelli L, et al.. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx. Histopathology. 2005, 46:576-82. 10.1111\/j.1365-2559.2005.02141.x","journal-title":"Histopathology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.33160\/yam.2022.02.006","article-title":"Investigation of the subcellular localization-dependent anti- or pro-tumor functions of Maspin in human lung adenocarcinoma cell line","volume":"65","author":"Matsushige T","year":"2022","unstructured":"Matsushige T, Sakabe T, Umekita Y. Investigation of the subcellular localization-dependent anti- or pro-tumor functions of Maspin in human lung adenocarcinoma cell line. Yonago Acta Med. 2022, 65:44-52. 10.33160\/yam.2022.02.006","journal-title":"Yonago Acta Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnci.2017.09.002","article-title":"Maspin expression and subcellular localization in invasive ductal carcinoma of the breast: Prognostic significance and relation to microvessel density","volume":"29","author":"Helal DS","year":"2017","unstructured":"Helal DS, El-Guindy DM. Maspin expression and subcellular localization in invasive ductal carcinoma of the breast: Prognostic significance and relation to microvessel density. J Egypt Natl Canc Inst. 2017, 29:177-83. 10.1016\/j.jnci.2017.09.002","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref18","article-title":"Correlation of angiogenesis with other immunohistochemical markers in cutaneous basal and squamous cell carcinomas","volume":"56","author":"Ciortea CD","year":"2015","unstructured":"Ciortea CD, Jung I, Gurzu S, K\u00f6vecsi A, Turdean SG, Bara T. Correlation of angiogenesis with other immunohistochemical markers in cutaneous basal and squamous cell carcinomas. Rom J Morphol Embryol. 2015, 56:665-70.","journal-title":"Rom J Morphol Embryol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2015.783","article-title":"Tumor suppressor maspin as a modulator of host immune response to cancer","volume":"15","author":"Dzinic SH","year":"2015","unstructured":"Dzinic SH, Bernardo MM, Oliveira DS, Wahba M, Sakr W, Sheng S. Tumor suppressor maspin as a modulator of host immune response to cancer. Bosn J Basic Med Sci. 2015, 15:1-6. 10.17305\/bjbms.2015.783","journal-title":"Bosn J Basic Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12391","article-title":"Salivary proteome profiling of oral squamous cell carcinoma in a Hungarian population","volume":"8","author":"Cs\u0151sz \u00c9","year":"2018","unstructured":"Cs\u0151sz \u00c9, M\u00e1rkus B, Darula Z, et al.. Salivary proteome profiling of oral squamous cell carcinoma in a Hungarian population. FEBS Open Bio. 2018, 8:556-69. 10.1002\/2211-5463.12391","journal-title":"FEBS Open Bio"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1139\/o11-053","article-title":"An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis","volume":"90","author":"Goulet B","year":"2012","unstructured":"Goulet B, Chan G, Chambers AF, Lewis JD. An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis. Biochem Cell Biol. 2012, 90:22-38. 10.1139\/o11-053","journal-title":"Biochem Cell Biol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063581","article-title":"Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC)","volume":"8","author":"Wang Y","year":"2013","unstructured":"Wang Y, Sheng S, Zhang J, et al.. Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC). PLoS One. 2013, 8:e63581. 10.1371\/journal.pone.0063581","journal-title":"PLoS One"},{"key":"ref23","article-title":"[Mammary serine proteinase inhibitor subcellular expression in oral squamous cell carcinoma and its clinical significance]","volume":"46","author":"Luo J","year":"2011","unstructured":"Luo J, Shu HR, Ying YK, Wu WL, Ji T, Zhong LP. [Mammary serine proteinase inhibitor subcellular expression in oral squamous cell carcinoma and its clinical significance]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2011, 46:505-9.","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.12.4285","article-title":"Quantitative proteomic analysis of non-tobacco associated oral squamous cell carcinoma reveals deregulation of cytoskeletal and apoptotic proteins","volume":"23","author":"T A S","year":"2022","unstructured":"T A S, Narayan M, Krishnan R, Thayalan D, Gunasekaran N, S P. Quantitative proteomic analysis of non-tobacco associated oral squamous cell carcinoma reveals deregulation of cytoskeletal and apoptotic proteins. Asian Pac J Cancer Prev. 2022, 23:4285-92. 10.31557\/APJCP.2022.23.12.4285","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/533079-serpin-b5-as-a-potential-biomarker-for-the-diagnosis-and-prognosis-of-oral-squamous-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:56:43Z","timestamp":1788634603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/533079-serpin-b5-as-a-potential-biomarker-for-the-diagnosis-and-prognosis-of-oral-squamous-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.115829","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,5]]}}}